Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Supaliv
- Development stage
- Unknown
- Lead developer
- TIMA Japan
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Supaliv is a nutraceutical product developed and marketed by Bion Therapeutics (India) Private Limited, primarily positioned for liver support and the management of metabolic disorders. Described as an ayurvedic preparation, it is utilized for conditions such as non-alcoholic fatty liver disease (NAFLD) and metabolic syndrome. The product is available in a syrup formulation (200ml) as well as capsules. Although the specific active ingredients and molecular mechanism of action are not publicly disclosed, it is part of the company's Pharma Wellness portfolio and is commercially available through pharmacy channels in India.
- Brand names
- Supaliv
Beyond the preview
Go deeper on Supaliv.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Supaliv.